Search for a research project
Other search option(s)
48 Result(s)
Terminated research projects = 
Funded by an IRDiRC member = 
Study involving ERN members in at least two Member States = 
Research projects
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
WIEN
PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT
Gesundheit Österreich GmbH
AUSTRIA
WIEN
WIEN
Christian Doppler Laboratory for Next Generation CAR-T Cells
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
AUSTRIA
WIEN
WIEN
Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy - AT
St. Anna Kinderkrebsforschung
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - BE
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - BE
EORTC
European Organisation for the Research and Treatment of Cancer
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation
Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)
CANADA
Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute
GERMANY
Baden-Württemberg
FREIBURG
MTB-FR: Register study of the Molecular Tumor Board (tumor entity-spanning molecular characterization program to evaluate individualized tumor biology-guided therapy in adults with rare and advanced tumor entities
Universitätsklinikum Freiburg
Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation
GERMANY
Baden-Württemberg
HEIDELBERG
ERA-NET TRANSCAN: BRCAddict - BRCAness as a therapeutic target for solid high-risk childhood tumors
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg
GERMANY
Bayern
AUGSBURG
CancerEvo: Investigation of evolution in sporadic and tumor disposition syndrome-associated tumors
Universitätsklinikum Augsburg
II. Medizinische Klinik
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
Entwicklung eines Moduls zur Bewertung der finanziellen Belastung von Patienten Finanzielle Belastung im Zusammenhang mit der Krebsbehandlung - Finanzielle Toxizität-Phase I
Institution: Information not provided - DE
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - DE
ISRAEL
ISRAEL
ADDRESS: NOT PROVIDED - IL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - IL
Institution: Information not provided - IL
ISRAEL
ISRAEL
ADDRESS: NOT PROVIDED - IL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - IL
ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - IT
Institution: Information not provided - IT
ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - IT
ITALY
VENETO
PADOVA
Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS
NETHERLANDS
Utrecht
ADDRESS: NOT PROVIDED - NL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - NL
Institution: Information not provided - NL
NETHERLANDS
Utrecht
ADDRESS: NOT PROVIDED - NL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - NL
PORTUGAL
CENTRO
ADDRESS: NOT PROVIDED - PT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - PT
Institution: Information not provided - PT
PORTUGAL
CENTRO
ADDRESS: NOT PROVIDED - PT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - PT
SWITZERLAND
Suisse Alémanique
BERN
Disease-targeted next-generation sequencing panel (VASCSequ) for detection of somatic-mosaic mutations in congenital vascular malformations to enable further advances in personalized therapeutic decision making
Universitätsspital Inselspital
Universitätsklinik für Angiologie
TURKEY
TURKEY
ADDRESS: NOT PROVIDED - TR
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - TR
Institution: Information not provided - TR
TURKEY
TURKEY
ADDRESS: NOT PROVIDED - TR
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - TR
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - UK
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US
SPAIN
Andalucía
SEVILLA
Mechanistic models using Machine Learning for therapeutic targets discovery and drug repurposing in Rare Diseases
Fundación Progreso y Salud
Área de bioinformática clínica
CANADA
Colombie-Britannique
VICTORIA
Silent Genomes: Reducing health care disparities and improving diagnostic success for children with genetic diseases from Indigenous populations
University of Victoria
Community Genetics Research Program/Island Medical Program
SPAIN
Andalucía
SEVILLA
Development of bioinformatic tools for the automatic handling of secondary findings and their use in genetic and pharmacogenetic counseling
Fundación Progreso y Salud
Área de bioinformática clínica
SPAIN
Andalucía
SEVILLA
Development of a repository of genomic analysis workflows
Fundación Progreso y Salud
Área de bioinformática clínica
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Centro de Regulación Genómica
Archivo europeo de genomas y fenomas del CRG
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Clínic de Barcelona
Servicio de Inmunologia
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Universitari Vall d'Hebron
Laboratorio de Genética
SPAIN
Cataluña
BARCELONA
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital de la Santa Creu i Sant Pau
Servicio de Genética
SPAIN
Cataluña
ESPLUGUES DE LLOBREGAT
Federated network for functional genomics of undiagnosed and rare diseases, RareFunction
Fundació Sant Joan de Déu - Institut de Recerca Sant Joan de Déu
Grupo de Neurogenética y Medicina Molecular
SPAIN
Cataluña
ESPLUGUES DE LLOBREGAT
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Sant Joan de Déu Barcelona
Servicio de Laboratorio
SPAIN
Cataluña
L'HOSPITALET DE LLOBREGAT
Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Universitari de Bellvitge
Unidad de Genética Molecular
SPAIN
Madrid
MADRID
Identification of new genes causing rare diseases in pediatric patients, searching of genetic pharmacological targets, and drugs discovery, the steps for a personalized medicine
Instituto de Investigación Hospital 12 de Octubre
Grupo de Enfermedades raras, mitocondriales y neuromusculares
Multicentric Research projects
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Institution: Information not provided - DE
- Tata Memorial Centre
- Advanced Centre for Treatment, Research and Education in Cancer
- Institution: Information not provided - IT
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- Northern Institute for Cancer Research, Medical School, Newcastle University
- Northern Institute for Cancer Research
- Institut Curie
- Macromolécules et Microsystèmes en Biologie et en Medecine
AUSTRIA
WIEN
WIEN
ExPO-r-Net: European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
TORPEDO: Targeting Of Resistance in PEDiatric Oncology
INDIA
INDIA
MAHARASHTRA
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I
ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities
ITALY
LOMBARDIA
MILANO
RARECARE: surveillance of rare cancers in Europe
UNITED KINGDOM
Tyne & Wear
NEWCASTLE UPON TYNE
EPOC: European paediatric oncology off-patent medicines consortium
FRANCE
ILE-DE-FRANCE
ORSAY